IGC Pharma (IGC) Deferred Taxes (2010 - 2016)
IGC Pharma (IGC) reported Deferred Taxes of $579.0 for Q1 2016, down 81.49% year-over-year from $3128.0 in Q2 2015, and down 81.49% quarter-over-quarter from $3128.0 in Q1 2015.
IGC Pharma (IGC) Deferred Taxes (2010 - 2016) Analysis & Trends
IGC Pharma (IGC) has 7 years of Deferred Taxes data on file, last reported at $579.0 in Q1 2016.
- Deferred Taxes for Q1 2016 came in at $579.0, down 81.49% year-over-year; the trailing twelve-month figure through Mar 2016 was $3707.0 (up 18.51% YoY), and the FY2017 annual result was $18968.0, up 3175.99% from the prior year.
- Deferred Taxes retreated to $579.0 in Q1 2016 per IGC's latest filing, from $3128.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $863953.0 in Q1 2012 and troughed at -$522498.0 in Q1 2013.
- A 5-year average of $33176.5 and a median of $1596.0 in 2013 frame the typical range for Deferred Taxes.
- On a YoY basis, Deferred Taxes climbed as much as 278.51% in 2013 and fell as far as 160.48% in 2013.
- A 5-year view of Deferred Taxes shows it stood at $498.0 in 2012, then soared by 278.51% to $1885.0 in 2013, then surged by 684.67% to $14791.0 in 2014, then tumbled by 78.85% to $3128.0 in 2015, then tumbled by 81.49% to $579.0 in 2016.
- Business Quant data shows IGC's Deferred Taxes at $579.0 in Q1 2016, $3128.0 in Q1 2015, and $14791.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 579.00 |
| Mar 31, 2015 | 3,128.00 |
| Mar 31, 2014 | 14,791.00 |
| Dec 31, 2013 | 1,885.00 |
| Sep 30, 2013 | 1,507.00 |
| Jun 30, 2013 | 1,596.00 |
| Mar 31, 2013 | -522,498.00 |
| Dec 31, 2012 | 498.00 |
| Sep 30, 2012 | 3,040.00 |
| Jun 30, 2012 | -3,538.00 |
| Mar 31, 2012 | 863,953.00 |
| Mar 31, 2011 | 4.55 Mn |
| Dec 31, 2010 | 7,285.00 |
| Sep 30, 2010 | 17,951.00 |
| Jun 30, 2010 | -474,871.00 |